journal article·2017-07-04

Enhancing antitumor activity of silver nanoparticles by modification with cell-penetrating peptides

Samad Mussa Farkhani, Abbas Asoudeh Fard, Parvin Zakeri-Milani, Javid Shahbazi Mojarrad, Hadi Valizadeh

Publisher page

Abstract

Recently, silver nanoparticles (AgNPs) have been used for cancer treatment. To achieve a successful anticancer activity, AgNP needs to be delivered sufficiently to the cells. Cell-penetrating peptides (CPPs) are small cationic peptides that have ability to transport various cargos across cell membranes. In this study, a strategy was developed for cancer treatment, where AgNP modified with CPPs displayed dramatically antitumor activity in MCF-7 cell lines. Peptides-modified AgNPs showed significant enhancement in killing tumor cells by increasing the uptake of AgNP into cell lines and could be a new class of nano-drug for cancer treatment.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Graphene and Nanomaterials Applications · Advanced biosensing and bioanalysis techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Research Center for Pharmaceutical Nanotechnology and Department of Medical Nanotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran;

Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran;

Liver and Gastrointestinal Diseases Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran;

Biotechnology Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran;

Drug Applied Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran

References (34)

Show source-provided references
1. 10.1021/nn800596w10.1021/nn800596w ↗
2. 10.1096/fj.12-21617610.1096/fj.12-216176 ↗
3. Bondar OV · Acta Naturae · 2012 · 4 · 7810.32607/20758251-2012-4-1-78-81 ↗
4. 10.3109/21691401.2015.103190610.3109/21691401.2015.1031906 ↗
5. 10.1049/iet-nbt.2015.003010.1049/iet-nbt.2015.0030 ↗
6. 10.1016/j.peptides.2014.04.01510.1016/j.peptides.2014.04.015 ↗
7. 10.1016/j.colsurfb.2012.12.04410.1016/j.colsurfb.2012.12.044 ↗
8. 10.1016/j.chembiol.2008.03.01510.1016/j.chembiol.2008.03.015 ↗
9. 10.1016/j.jconrel.2011.06.00410.1016/j.jconrel.2011.06.004 ↗
10. 10.1016/j.colsurfb.2013.01.02710.1016/j.colsurfb.2013.01.027 ↗
11. 10.1016/j.bbamem.2014.11.01310.1016/j.bbamem.2014.11.013 ↗
12. 10.1016/j.fct.2012.08.04410.1016/j.fct.2012.08.044 ↗
13. 10.1016/j.canlet.2012.06.00810.1016/j.canlet.2012.06.008 ↗
14. 10.1016/j.biomaterials.2011.10.05810.1016/j.biomaterials.2011.10.058 ↗
15. 10.1021/la034181510.1021/la0341815 ↗
16. 10.1016/j.colsurfb.2013.05.03810.1016/j.colsurfb.2013.05.038 ↗
17. 10.1016/j.biomaterials.2012.05.03510.1016/j.biomaterials.2012.05.035 ↗
18. 10.3109/17435390.2010.48374510.3109/17435390.2010.483745 ↗
19. 10.1002/anie.20110257210.1002/anie.201102572 ↗
20. 10.1016/j.biomaterials.2013.09.04510.1016/j.biomaterials.2013.09.045 ↗
21. 10.1049/iet-nbt.2012.002810.1049/iet-nbt.2012.0028 ↗
22. 10.1016/j.jconrel.2012.01.01610.1016/j.jconrel.2012.01.016 ↗
23. 10.1039/c2mb25467k10.1039/c2mb25467k ↗
24. 10.1016/j.biomaterials.2013.03.04910.1016/j.biomaterials.2013.03.049 ↗
25. 10.1021/bi300454k10.1021/bi300454k ↗
26. 10.1021/am100840c10.1021/am100840c ↗
27. 10.2147/IJN.S1172710.2147/IJN.S11727 ↗
28. 10.1016/j.procbio.2011.11.00310.1016/j.procbio.2011.11.003 ↗
29. 10.1088/0957-4484/23/37/37510210.1088/0957-4484/23/37/375102 ↗
30. 10.1088/0957-4484/21/17/17510410.1088/0957-4484/21/17/175104 ↗
31. 10.1016/j.addr.2014.08.00210.1016/j.addr.2014.08.002 ↗
32. 10.1155/2010/94854310.1155/2010/948543 ↗
33. 10.1016/j.drudis.2011.09.00910.1016/j.drudis.2011.09.009 ↗
34. 10.1021/ja304180y10.1021/ja304180y ↗